'Fatigue' in multiple sclerosis;'Fatigue' bei multipler sklerose

Nervenarzt

Volumn 70, Issue 6, 1999, Pages 566-574

  Zimmermann, Carolin ^a   Hohlfeld, R ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Institut für Klinische Radiologie   (Germany)

Author keywords

Amantadin; Aminopyridine; Fatigue; Multiple sclerosis; Therapy

Indexed keywords

AMANTADINE; AMINOPYRIDINE; AMINOPYRIDINE DERIVATIVE; PEMOLINE; POTASSIUM CHANNEL BLOCKING AGENT;

ARTICLE; CENTRAL NERVOUS SYSTEM; CONFUSION; DRUG OVERDOSE; EXERCISE TOLERANCE; EXHAUSTION; FATIGUE; HUMAN; MULTIPLE SCLEROSIS; NERVE CONDUCTION; PATHOPHYSIOLOGY; SEIZURE; DISEASE COURSE; FEMALE; HOSPITALIZATION; MALE; REVIEW;

AMANTADINE; AMINOPYRIDINES; DISEASE PROGRESSION; FATIGUE; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; PEMOLINE; POTASSIUM CHANNEL BLOCKERS; SEVERITY OF ILLNESS INDEX;

EID: 0032936936     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050482     Document Type: Article

References (42)

1. Bever CT (1994) The current status of studies of aminopyridines in patients with multiple sclerosis. Ann Neurol 36: S118-S121
2. Bever CT, Anderson PA, Leslie J, Panitch HS, Dhib-Jalbut S, Khan OA, Milo R, Hebel JR, Conway KL, Katz E, Johnson KP (1996) Treatment with oral 3,4 diaminopyridine improves leg strengh in multiple sclerosis patients. Neurology 47:1457-1462
3. Bever CT,Young D, Anderson PA, Krumholz A, Conway K, Leslie J, Eddington N, Plaisance KI, Panitch HS, Dhib-Jalbut S, Fossler MJ, Devane J, Johnson KP (1994) The effects of 4-amino-pyridine in multiple sclerosis patients. Neurology 44:1054-1059
4. Canadian MS Research Group (1987) A randomized controlled trail of amantadine in fatigue associated with multiple sclerosis. Can J Neurol Sci 14:273-278
5. Cohen RA, Fisher M (1989) Amantadine treatment of fatigue associated with multiple sclerosis. Arch Neurol 46:676-680
6. Davis FA, Stefoski D, Quandt FN (1995) Mechanism of action of 4-aminopyridine in the symptomatic treatment of multiple sclerosis. Ann Neurol 37:684
7. Dickinson CJ (1997) Chronic fatigue syndrome - aetiological aspects. Eur J Clin Invest 27:257-267
8. Ditzen G, Gerst F, Hänsel W, Koppenhöfer E (1995) Kaliumkanalblocker - ein neuer Ansatz zur symptomatischen Therapie der multiplen Sklerose. Dtsch Med Wochenschr 120:1061-1062
9. Djaldetti R, Ziv I, Achiron A, Melamed E (1996) Fatigue in multiple sclerosis compared with chronic fatigue syndrome: a quantitave assessment. Neurology 46:632-635
10. Felts PA, Smith KJ (1994) The use of potassium channel blocking agents in therapy of demyelinating diseases. Ann Neurol 36:454
11. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ (1994) The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci 21:9-14
12. Freal JE, Kraft GH, Coryell JK (1984) Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 65:135-138
13. Guthrie TC, Nelson DA (1995) Influence of temperature changes on multiple sclerosis: critical review of mechanisms and research potential. J Neurol Sci 129:1-8
14. Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richer JR, Salazar AM, Fisher JS, Goodkin DE, Granger CV (1996) Intramuscular Interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative research group. Ann Neurol 39:285-294. Avonex briefing document, phase III trial (1997)
15. Kemp BA, Gora ML (1993) Amantadine and fatigue of multiple sclerosis. Ann Pharmacother 27:893-895
16. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC (1988) Fatigue in multiple sclerosis. Arch Neurol 45:435-437
17. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematodes. Arch Neurol 46:1121-1123
18. Krupp LB, Coyle MD, Doscher C, Miller A, Cross AH, Jandorf L, Halper J, Johnson B, Morgante L, Grimson R (1995) Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 45: 1956-1961
19. Krupp LB, Pollina DA (1996) Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 9: 456-460
20. Multiple Sclerosis Council for clinical practice guidelines (1998) Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis.
21. Murray TJ (1985) Amantadine therapy for fatigue in multiple sclerosis. Can Neurol Sci 12:251-254
22. Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK (1993) A comparison of neuropsychiatrie characteristics in chronic fatigue syndrome, multiple sclerosis and major depression. J Neuropsychiatr Clin Neurosci 5:200-205
23. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW (1996) Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 39:432-441
24. Pliskin NH, Hamer DP, Goldstein DS, Towle VL, Reder AT, Noronha A, Arnason BGW (1996) Improved delayed visual reproduction test performance in multiple sclerosis patients recieving Interferon beta-1b. Neurology 47: 1463-1468
25. Polman CH, Bertelsmann FW, vanLoenen AC, Koetsier JC (1994) 4-Aminopyridine in the treatment of patients with multiple sclerosis. Arch Neurol 51:292-296
26. Rice CL, Volmer TL, Bigland-Ritchie B (1992) Neuromuscular responses of patients with multiple sclerosis. Muscle Nerve 15: 1123-1132
27. Richards TL, Lappin MS, Acosta-Urquidi J, Kraft GH, Heide AC, Lawrie FW, Merrill TE, Melton GB, Cunningham CA (1997) Double-blind study of pulsing magnetic field effects on multiple sclerosis. J Altern Complement Med 3: 21-29
28. Ritchie JM (1984) Pathophysiology of conduction in demyelinated fibers. In: Morrel P (ed) Myelin. Plenum, New York, pp 337-367
29. Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Ammann W, Plohmann A, Dellas S, Maguire RP, Missimer J, Radü EW, Steck A, Leenders KL (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48:1566-1571
30. Rosenberg GA, Appenzeller O (1988) Amantadine, fatigue and multiple sclerosis. Arch Neurol 45:1104-1106
31. Sandroni P, Walker C, Starr A (1992) Fatigue in patients with multiple sclerosis. Motor pathway conduction and event related potentials. Arch Neurol 49:517-524
32. Sandyk R (1996) Treatment with weak electromagnetic fields improves fatigue associated with multiple sclerosis, Int J Neurosci 84:177-186
33. Sandyk R (1997) Immediate recovery of cognitive functions and resolution of fatigue by treatment with weak electromagnetic fields in a patient with multiple sclerosis. Int J Neurosci 90:59-74
34. Schwartz RB, Garada BM, Komaroff AL (1994) Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. Am J Roentgenol 162:935-941
35. Scott PJ, Huskisson EC (1977) Measurement of functional capacity with visual analogue scales. Rheumatol Rehabil 16:257-259
36. Sheean GL, Murray NMF, Rothwell JC, Miller DH, Thompson AJ (1997) An electrophysiological study of the mechanism of fatigue in multiple sclerosis. Brain 120:299-315
37. Sheean GL, Murray NMF, Rothwell JC, Miller DH, Thompson AJ (1998) An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis. Brain 121: 867-975
38. Smits RCF, Emmen HH, Bertelsmann FW, Kulig BM, vanLoenen AC, Polman CH (1994) The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis: a pilot study. Neurology 44:1701-1705
39. Stefoski D, Davis FA, Faut M, Schauf CL (1987) 4-Aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol 21:71-77
40. Straus SE, Dale JK Tobi M et al (1988) Acyclovir treatment of the chronic fatigue syndrome, lack of efficacy in a placebo-controlled trial. N Engl J Med 319:1692-1698
41. vanDiemen HA, Polman CH, vanDongen MM, Nauta JJ, Taphoorn MJ et al (1991) The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double blind, cross-over study. Ann Neurol 32:123-130
42. Weinshenker BG, Penman M, Bass B, Ebers GC, Rice GPA (1992) A double-blind, randomized, crossover trial of Pemolin in fatigue associated with multiple sclerosis. Neurology 42:1468-1471